Compare Sariguna Primatirta Tbk. (CLEO) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sariguna Primatirta Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Sariguna Primatirta Tbk. trades at Rp384 (market cap 9.22T), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B). The key difference: Sariguna Primatirta Tbk. is far larger — about 55.1× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| CLEO | OBAT | |
|---|---|---|
Market Cap | 9.22T | 167.37B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sariguna Primatirta Tbk.
PT Sariguna Primatirta Tbk (the Company) was established on March 10, 1988 by Notarial Deed No. 87 of Soetjipto, S.H. Tanobel is the identity of PT Sariguna Primatirta, its first operation in 17th September 2003. Produced Drinking Water in Package, processed from Mount Arjuna Spring in Pandaan. In 7 March 2004, Cleo Pure Water launched as one of Tanobel superior products in various package. Such as 250 ml cup, 330 ml bottle, 550 ml bottle, 1200 ml bottle, 6 L gallon and 19 L gallon. After that, Tanobel spread its Cleo Pure Water production to various cities in Indonesia. Now, Tanobel has factories, that had equipped with integration process. From raw material provision, cup, bottle and gallon packaging until finished product. It also has strict supervision on quality and high production standard. PT Sariguna Prima Tirta in October 2008 gets international recognition ISO 9001:2000, and in October 2008 gets ISO 22000:2005.
Read more on CLEO →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
